A partnership with the Dubai Health Authority and AXA insurance was created with the common objective of developing a sustainable solution that provides sufficient funding to give access to innovative cancer treatment to the most vulnerable in society.

Roche supported the creation of a common fund (BASMAH) within insurance companies, to pay for cancer screening, diagnosis and treatment that goes beyond the annual insurance limit.

We achieved this by increasing insurance premiums by $5 per person, per year and to be paid by the employer. This fund will cover screening, advanced diagnostics and full treatment of breast, colorectal & cervical cancers. It will be extended to other disease areas in phase II.